Eltrombopag Viatris

Eltrombopag Viatris is a medication used to stimulate platelet production. It is commonly prescribed for conditions affecting blood cell counts, such as thrombocytopenia. This oral medication is manufactured by Viatris Limited and is available in the EU market.

Eltrombopag Viatris is primarily used to increase platelet counts in individuals with certain blood disorders. It is often prescribed for conditions like chronic immune thrombocytopenia (ITP), where the body does not produce enough platelets. This medication works by stimulating the bone marrow to produce more platelets, which are essential for blood clotting and preventing excessive bleeding.

Common effects of Eltrombopag Viatris may include nausea, fatigue, and mild abdominal pain. Some users might experience changes in liver function, so regular monitoring is advised. It is important to discuss any persistent or severe side effects with a healthcare provider.

Eltrombopag Viatris should be handled with care, especially by individuals with liver conditions. It is important to follow the prescribed dosage and administration guidelines. Pregnant or breastfeeding women should consult a healthcare provider before using this medication.

Eltrombopag Viatris may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.